# NRX Pharmaceuticals, Inc.: Form 8-K, filed Sep 12, 2025

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: 8-K
- Filed: 2025-09-12
- Accepted by EDGAR: Sep 12, 2025, 16:33 ET
- Period: 2025-09-08
- Accession: 0001437749-25-028949
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/nrxp20250912_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/nrxp20250912_8k.htm

Filed Sep 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-028949. Last ingested by Listed: Nov 5, 2026, 19:01 ET. No prices; not investment advice.